As of 2025-10-30, the Relative Valuation of Oncternal Therapeutics Inc (ONCT) is (180.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on Relative Valuation is -34370.3%.
The range of the Relative Valuation is (144.84) - (200.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 17.1x | 15.5x |
| Forward P/E multiples | 12.3x - 18.7x | 15.4x |
| Fair Price | (144.84) - (200.21) | (180.47) |
| Upside | -27605.0% - -38119.0% | -34370.3% |
| Date | P/E |